14 drug(s) with this reaction
6,259 total reports
Product Quality Issue has been reported as an adverse reaction across 14 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 6,259 adverse event reports mention product quality issue in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with product quality issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have product quality issue listed in their FDA adverse event reports, sorted by report count:
In addition to product quality issue, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
14 drug(s) manufactured by Haleon Us Holdings Llc have product quality issue listed in their FDA adverse event reports: NICOTINE POLACRILEX, NICOTINE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ORLISTAT, and others.
There are a combined 6,259 reports of product quality issue across 14 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.